Standout Papers

<sup>18</sup>F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A... 2010 2026 2015 2020 499
  1. 18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial (2010)
    Rik Vandenberghe, Koen Van Laere et al. Annals of Neurology

Immediate Impact

6 by Nobel laureates 7 from Science/Nature 57 standout
Sub-graph 1 of 20

Citing Papers

Hallmarks of neurodegenerative diseases
2023 Standout
Trial of Solanezumab in Preclinical Alzheimer’s Disease
2023 Standout
8 intermediate papers

Works of Eric Triau being referenced

18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
2010 Standout

Author Peers

Author Last Decade Papers Cites
Eric Triau 457 190 379 8 720
Virginia Pappas 441 162 544 8 749
Barbara Schaffer 293 128 192 9 577
Marita Kailajärvi 398 161 384 18 742
Stephanie Reeder 594 103 447 3 789
Adi Alkalay 503 135 430 9 685
Mariella Lauriola 338 73 257 5 607
J. Koivunen 575 145 596 8 766
J. Pacheco 251 225 190 5 751
Janna Arteaga 438 186 209 15 736
Vijaya L. Melnick 312 54 390 8 834

All Works

Loading papers...

Rankless by CCL
2026